Comparison of Trigger Point Release Technique of Repetitive Needling with Lignocaine versus Lignocaine Plus Steroid in Management of Myofascial Trigger Points – A Randomized Controlled Trialâ€
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 入组人数
- 66
- 试验地点
- 1
- 主要终点
- pain scores measured by the visual analogue scale (VAS) in which 0 indicated no pain and 10 indicated the most intense pain imaginable.
研究概览
简要总结
Patients satisfying the inclusion and exclusion criteria will be managed conservatively for 1 week as per standard care plan. After 1 week if pain is persisting will taken up for intervention. Patient will be divided into 2 groups by envelope method , group 1 will receive 5 ml 2% Lignocaine with adrenaline (1:200000) (ATD) and Group 2 will receive 4ml 2% Lignocaine with adrenaline (1:200000) (ATD) and 1 ml 40 mg/ml Triamcinolone Acetate with 24G needle followed by repeated needling techniques. Pre procedure VAS & WHOQOL BREF will be assessed. Patient will be reassessed in 2 weeks and 6 weeks with VAS & WHOQOL BREF.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients diagnosed with Myofascial trigger points of any duration.
- •FaileConservative trial of management tried for at least1 week.
排除标准
- 未提供
结局指标
主要结局
pain scores measured by the visual analogue scale (VAS) in which 0 indicated no pain and 10 indicated the most intense pain imaginable.
时间窗: Baseline 2 weeks and 6 weeks
次要结局
- Quality of Life Assessment using WHO Bref questieneir(WHO Bref questioneir will be assessed before the procedure and 6 weeks after the procedure.)
研究者
DR REVATHY S M
AIIMS RAIPUR